200 related articles for article (PubMed ID: 21369643)
1. Salicylic Acid 6% in an ammonium lactate emollient foam vehicle in the treatment of mild-to-moderate scalp psoriasis.
Kircik L
J Drugs Dermatol; 2011 Mar; 10(3):270-3. PubMed ID: 21369643
[TBL] [Abstract][Full Text] [Related]
2. A lipohydroxyacid-containing shampoo improves scalp condition and quality of life in patients with seborrheic dermatitis and light-to-moderate scalp psoriasis.
Seité S; Paries J; Reygagne P; Hamidou Z; Jouanique C; Perez-Pala G; Rougier A
J Cosmet Dermatol; 2009 Jun; 8(2):108-13. PubMed ID: 19527334
[TBL] [Abstract][Full Text] [Related]
3. Mometasone furoate 0.1% and salicylic acid 5% vs. mometasone furoate 0.1% as sequential local therapy in psoriasis vulgaris.
Tiplica GS; Salavastru CM
J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):905-12. PubMed ID: 19470062
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of Iralfaris shampoo in the treatment of scalp psoriasis: a videodermoscopy evaluation prospective study in 70 patients.
Rossi A; Pranteda G; Iorio A; Mari E; Milani M
G Ital Dermatol Venereol; 2012 Dec; 147(6):625-30. PubMed ID: 23149708
[TBL] [Abstract][Full Text] [Related]
5. Better medication adherence results in greater improvement in severity of psoriasis.
Carroll CL; Feldman SR; Camacho FT; Balkrishnan R
Br J Dermatol; 2004 Oct; 151(4):895-7. PubMed ID: 15491434
[TBL] [Abstract][Full Text] [Related]
6. Topical tacrolimus ointment combined with 6% salicylic acid gel for plaque psoriasis treatment.
Carroll CL; Clarke J; Camacho F; Balkrishnan R; Feldman SR
Arch Dermatol; 2005 Jan; 141(1):43-6. PubMed ID: 15655140
[TBL] [Abstract][Full Text] [Related]
7. Scalp psoriasis.
Kircik LH; Kumar S
J Drugs Dermatol; 2010 Aug; 9(8 Suppl ODAC Conf Pt 2):s101-5. PubMed ID: 20715392
[TBL] [Abstract][Full Text] [Related]
8. Psoriasis of the scalp. Diagnosis and management.
van de Kerkhof PC; Franssen ME
Am J Clin Dermatol; 2001; 2(3):159-65. PubMed ID: 11705093
[TBL] [Abstract][Full Text] [Related]
9. A new scalp formulation of calcipotriene plus betamethasone compared with its active ingredients and the vehicle in the treatment of scalp psoriasis: a randomized, double-blind, controlled trial.
Jemec GB; Ganslandt C; Ortonne JP; Poulin Y; Burden AD; de Unamuno P; Berne B; Figueiredo A; Austad J
J Am Acad Dermatol; 2008 Sep; 59(3):455-63. PubMed ID: 18694678
[TBL] [Abstract][Full Text] [Related]
10. Concomitant treatment of psoriasis of the hands and feet with pulsed dye laser and topical calcipotriol, salicylic acid, or both: a prospective open study in 41 patients.
de Leeuw J; Tank B; Bjerring PJ; Koetsveld S; Neumann M
J Am Acad Dermatol; 2006 Feb; 54(2):266-71. PubMed ID: 16443057
[TBL] [Abstract][Full Text] [Related]
11. Clobetasol propionate shampoo 0.05%: a new option to treat patients with moderate to severe scalp psoriasis.
Jarratt M; Breneman D; Gottlieb AB; Poulin Y; Liu Y; Foley V
J Drugs Dermatol; 2004; 3(4):367-73. PubMed ID: 15303780
[TBL] [Abstract][Full Text] [Related]
12. Treatment of psoriasis of the scalp with betamethasone 17, 21-dipropionate plus salicylic acid lotion ('Diprosalic').
Høvding G
Pharmatherapeutica; 1981; 3(1):61-6. PubMed ID: 7033993
[TBL] [Abstract][Full Text] [Related]
13. A new scalp formulation of calcipotriol plus betamethasone dipropionate compared with each of its active ingredients in the same vehicle for the treatment of scalp psoriasis: a randomized, double-blind, controlled trial.
van de Kerkhof PC; Hoffmann V; Anstey A; Barnes L; Bolduc C; Reich K; Saari S; Segaert S; Vaillant L
Br J Dermatol; 2009 Jan; 160(1):170-6. PubMed ID: 19067709
[TBL] [Abstract][Full Text] [Related]
14. Clinical benefit and tolerance profile of a keratolytic and hydrating shampoo in subjects with mild to moderate psoriasis. Results from a double-blind, randomized, vehicle-controlled study.
Massiot P; Pinto PC; Leclerc-Mercier S; Rasmont V; Piraccini BM; Rudnicka L; Reygagne P; Melo DF; Vano-Galvan S; Wu WY; Kerob D
J Cosmet Dermatol; 2023 Jul; 22(7):2050-2053. PubMed ID: 36942745
[TBL] [Abstract][Full Text] [Related]
15. A randomized, investigator-masked clinical evaluation of the efficacy and safety of clobetasol propionate 0.05% shampoo and tar blend 1% shampoo in the treatment of moderate to severe scalp psoriasis.
Griffiths CE; Finlay AY; Fleming CJ; Barker JN; Mizzi F; Arsonnaud S
J Dermatolog Treat; 2006; 17(2):90-5. PubMed ID: 16766333
[TBL] [Abstract][Full Text] [Related]
16. Clinical studies of a new vehicle formulation for topical corticosteroids in the treatment of psoriasis.
Stein L
J Am Acad Dermatol; 2005 Jul; 53(1 Suppl 1):S39-49. PubMed ID: 15968263
[TBL] [Abstract][Full Text] [Related]
17. Clobetasol propionate shampoo 0.05% and calcipotriol solution 0.005%: a randomized comparison of efficacy and safety in subjects with scalp psoriasis.
Reygagne P; Mrowietz U; Decroix J; de Waard-van der Spek FB; Acebes LO; Figueiredo A; Caputo R; Poncet M; Arsonnaud S
J Dermatolog Treat; 2005 Feb; 16(1):31-6. PubMed ID: 15897165
[TBL] [Abstract][Full Text] [Related]
18. Calcipotriol plus betamethasone dipropionate scalp formulation is effective and well tolerated in the treatment of scalp psoriasis: a phase II study.
Buckley C; Hoffmann V; Shapiro J; Saari S; Cambazard F; Milsgaard M
Dermatology; 2008; 217(2):107-13. PubMed ID: 18463448
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and tolerability of a cosmetically acceptable coal tar solution in the treatment of moderate plaque psoriasis: a controlled comparison with calcipotriene (calcipotriol) cream.
Alora-Palli MB; Perkins AC; Van Cott A; Kimball AB
Am J Clin Dermatol; 2010; 11(4):275-83. PubMed ID: 20513160
[TBL] [Abstract][Full Text] [Related]
20. Controlled study of excimer and pulsed dye lasers in the treatment of psoriasis.
Taibjee SM; Cheung ST; Laube S; Lanigan SW
Br J Dermatol; 2005 Nov; 153(5):960-6. PubMed ID: 16225606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
